Second vertical
A non-invasive neurodiagnostic device that captures biological signals at tissue source — a dimension of information not available to EEG, ECG, MRI or existing electrical diagnostic systems.
Beyond surface electricals.
Signals at tissue source.
Industrial-grade intelligence.
Every diagnostic modality in clinical use measures an electrical signal at the surface, or an image taken at a moment in time. Neither reaches the biology itself.
The Helmet applies sensor intelligence developed in industrial monitoring — the same noise analysis and pattern recognition used in demanding real-world environments — to read biological rather than mechanical signals, at source and in real time.
Greenverse is applying the platform to neurological disease and cancer-related biological-signal research, including potential use in CNS drug-trial monitoring.
This is an active research direction under clinical partnership. It is not a cleared diagnostic for brain cancer.
PCT international patent filed May 2026, covering 150+ contracting states.
Clinical partnerships established in the UK and Europe. Partner institutions are not publicly named.
The Greenverse Helmet is investigational and in clinical partnership. It is not a substitute for MRI or standard of care unless and until regulatory clearance is obtained.
We work with a small number of clinical and research partners.
For technical detail, partnership or evaluation enquiries, contact us directly.
